Phibro Animal Health (PAHC) Misses Q4 EPS by 2c, Revenues Beat
Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.36, $0.02 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $255.3 million versus the consensus estimate of $250.04 million.
GUIDANCE:
Phibro Animal Health sees FY 2023 revenue of $0.96-1 billion, versus the consensus of $910.21 million.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
